MDS Pharma Services Hires Beverly Harrison to Lead North American Clinical Operations from its King of Prussia Executive Offices
04 Ottobre 2004 - 4:56PM
PR Newswire (US)
MDS Pharma Services Hires Beverly Harrison to Lead North American
Clinical Operations from its King of Prussia Executive Offices
MONTREAL, Oct. 4 /PRNewswire-FirstCall/ -- MDS Pharma Services, a
leading provider of innovative drug discovery and development
solutions, has hired Beverly Harrison as vice president for
Clinical Operations in North America. Based at the King of Prussia,
Pa., office, her addition to the leadership team is a key milestone
in MDS Pharma Services' efforts to expand its Late State business
in North America. "Beverly's extensive industry experience, coupled
with her skills in strategic planning and change management, will
augment our strong management team in clinical operations and
provide leadership as we expand our business in North America,
particularly in the United States," says Alan Horgan, group vice
president, Late Stage Development. "Our commitment to the U.S.
region is demonstrated by the addition of someone of Beverly's
caliber to our team." Prior to joining MDS Pharma Services,
Harrison was president of Trilliant Research Inc. of Marlton, N.J.,
and vice president for Business Development and chief business
officer at Premier Research in Philadelphia, Pa. She played a key
role in facilitating Premier's acquisition of Trilliant in 2003.
Harrison's experience also includes executive positions at Covance
Inc. in Princeton, N.J., and clinical research project management
for Smith Kline Beckman (now GlaxoSmithKline) in Philadelphia. MDS
Pharma Services offers a full spectrum of resources to meet the
drug discovery and development needs of the pharmaceutical and
biotechnology industries. With numerous facilities strategically
located around the world, the company applies advanced scientific
and technological expertise to each stage of the drug discovery and
development process -- early stage: lead optimization, pre-IND
research, pharmaceutical and biopharmaceutical development, early
clinical research (bioequivalence, phases I-IIa) and bioanalysis;
and late stage: global clinical development (phases IIb-IV) and
central lab. For more information, visit MDS Pharma Services' Web
site at http://www.mdsps.com/. MDS Pharma Services is part of MDS
Inc. (TSX: MDS; NYSE: MDZ), an international health and life
sciences company. At MDS Inc., our 10,000 highly skilled people
provide services, products and instruments enabling health sciences
organizations to enhance the well being of people around the world.
We focus on helping discover and test new drugs, assisting doctors
to diagnose and treat patients and preventing the spread of
disease. Find out more about MDS Inc. (TSX: MDS; NYSE: MDZ), at
http://www.mdsintl.com/ or by calling 1-888-MDS-7222, 24 hours a
day. DATASOURCE: MDS Pharma Services CONTACT: or to receive a
high-resolution photograph of Beverly Harrison suitable for print
reproduction, please contact Charlene McGrady, MDS Pharma Services,
2200 Renaissance Boulevard, King of Prussia, Pa., Tel: (610)
239-7900, ext. 231, and visit our Web site at
http://www.mdsps.com/.
Copyright